ADmit Therapeutics is biotech company focused on the commerzalitation of the MAP-AD Test, the first epigenetic IVD Test for the prognosis of Alzheimer’s disease
Company Details
- Employees
- 13
- Founded
- -
- Address
- Crta. Laureà Miró, 408-410, Sant Feliu De Llobregat,barcelona 08980,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- admit-therapeutics.com
- HQ
- Sant Feliu de Llobregat, Barcelona
Admit Therapeutics Questions
Admit Therapeutics's website is admit-therapeutics.com
Admit Therapeutics's LinkedIn profile is https://es.linkedin.com/company/admit-therapeutics
Admit Therapeutics has
13 employees.
View email and phone details for 13
employees at Admit Therapeutics.
Admit Therapeutics's industry is
Biotechnology Research
Admit Therapeutics's top competitors are
Sycai Medical,
4bluetech,
Yplasma,
Sequentia Biotech,
M&a Fusiones Y Adquisiciones,
Time Is Brain,
Uniscool,
Casa Batlló, Gaudí Barcelona,
Estabanell,
Protofy.xyz.
Admit Therapeutics's categories are Biotechnology Research
Admit Therapeutics's founding year is 2017
